on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology plc
The Vanguard Group, Inc. has released a Form 8.3 filed with the Irish Takeover Panel concerning its interest in Mural Oncology plc. This disclosure is part of the requirements under Rule 8.3 of the Irish Takeover Panel Act, 1997, as updated in 2022. Vanguard reports a holding of 772,669 ordinary shares, representing a 4.47% stake in Mural Oncology.
The form, dated May 8, 2025, outlines no additional interests in other relevant securities or parties involved in the offer. Vanguard also engaged in a small purchase of 18 ordinary shares at a price of 2.59 USD each. The company stated no dealings in cash-settled or stock-settled derivatives.
No indemnity or options arrangements, agreements, or understandings relating to these securities were reported. Vanguard confirmed there are no supplemental forms attached to this disclosure.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news